Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study we have investigated a possible role for the proline-rich SH2 domain protein
Shb
as a regulator of expression or activity of certain SH3 domain proteins and MAP kinase. The expression of the
Shb
binding proteins Eps8, Src, and p85 PI3-kinase, PI3-kinase activity, and MAP kinase activation were assessed in wild-type NIH3T3 cells and in NIH3T3 cells overexpressing the
Shb
cDNA. In addition, the expression of the SH3 domain STAT1 proteins was assessed in wild-type and
Shb
overexpressing cells. The Eps8 protein content and Eps8 mRNA steady-state levels were downregulated, whereas the protein contents of Src and p85 PI3-kinase were unaffected by
Shb
overexpression. There was, however, an increased basal PI3-kinase activity in
Shb
transfected cells after a 3-h serum starvation. Increased steady-state levels of STAT1 mRNA were accompanied by an increased STAT1 protein content in
Shb
overexpressing cells.
Shb
overexpression was not associated with an altered activation of p44 or p42
MAP
kinases in response to PDGF stimulation. The data presented in this study suggest novel functions for the adaptor protein
Shb
regulating the expression of certain signal-transducing SH3 domain proteins and modulating PI3-kinase activity.
...
PMID:Modulation of Src homology 3 proteins by the proline-rich adaptor protein Shb. 908 67